AbbVie Inc (ABBV)

ABBV (NYSE:Drugs) EQUITY
$67.19
pos +0.01
+0.01%
Today's Range: 66.66 - 68.22 | ABBV Avg Daily Volume: 10,956,300
Last Update: 06/30/15 - 4:02 PM EDT
Volume: 11,625,858
YTD Performance: 2.67%
Open: $68.00
Previous Close: $67.18
52 Week Range: $51.37 - $70.76
Oustanding Shares: 1,593,076,097
Market Cap: 107,022,852,196
6-Month Chart
TheStreet Ratings Grade for ABBV
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 8 8 7
Moderate Buy 0 0 0 0
Hold 2 2 1 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.36 1.40 1.22 1.60
Latest Dividend: 0.51
Latest Dividend Yield: 3.04%
Dividend Ex-Date: 07/13/15
Price Earnings Ratio: 59.98
Price Earnings Comparisons:
ABBV Sector Avg. S&P 500
59.98 59.50 26.07
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
15.37% 19.05% 0.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue 6.20 0.14 0.05
Net Income -57.00 -0.48 -0.20
EPS -57.20 0.00 0.00
Earnings for ABBV:
EBITDA 4.95B
Revenue 19.96B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.06 $1.09 $4.27 $5.06
Number of Analysts 6 4 8 8
High Estimate $1.07 $1.11 $4.33 $5.38
Low Estimate $1.05 $1.05 $4.20 $4.75
Prior Year $0.82 $0.89 $3.32 $4.27
Growth Rate (Year over Year) 29.27% 22.19% 28.46% 18.73%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
The biotech's stock has likely peaked, as increased competition awaits in the Hep-C space.
New companies are coming up with major drugs.
Bullish
Jun 08, 2015 | 7:10 AM EDT
ABBV was placed on the Franchise Pick list, according to Jefferies. $90 price target. Estimates also increased, given a likely delay in...
The ABBV chart looks constructive, with solid volume and bullish indicators.
Acquisitions cut into overabundance of companies.
Many of these stocks are off to the races.
With a weak dollar, calm oil and tame rates, we're doing fine.
The market is a very happy place these days, so be careful.

Columnist Conversations

Met with the folks at Reebok yesterday -- came away very impressed by how they are repositioning the business ...
Baxter International (BAX) and Baxalta (BXLT) start trading separately today. Baxter's price may be erroneousl...
Pacific Crest analyst maintains his sector perform rating on Apple (AAPL) while raising his numbers going forw...
The S&P 500 Index is near a key Fibonacci time period in the time zone sequence measured off the 2009 low,...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.